Skip to content

Screener

Eligibility screening

A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia

Sponsored by Novo Nordisk A/SStudy detailsClinicalTrials.gov

2 US sites in CA, MD

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.